ARIAD GETS ORPHAN DRUG DESIGNATION FOR AP23573.: An article from: Biotech Business

This digital document is an article from Biotech Business, published by Thomson Gale on October 1, 2005. The length of the article is 560 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: ARIAD GETS ORPHAN DRUG DESIGNATION FOR AP23573.
Publication:Biotech Business (Newsletter)
Date: October 1, 2005
Publisher: Thomson Gale
Volume: 18 Issue: 10 Page: NA

Distributed by Thomson Gale